COMMUNIQUÉS West-GlobeNewswire

Publication relative à des notifications de transparence

15/10/2024 - 22:30

INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 15 octobre 2024 , 22:30h CET / 16:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative [...]

CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024

15/10/2024 - 22:30

MINNEAPOLIS, Oct. 15, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative [...]

Amwell announces new chief financial officer

15/10/2024 - 22:30

Industry veteran Mark Hirschhorn joins Amwell leadership team BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, today announced Mark Hirschhorn will become Amwell Chief Financial [...]

Globus Medical Schedules Third Quarter Earnings Release and Conference Call

15/10/2024 - 22:30

AUDUBON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2024 after [...]

Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

15/10/2024 - 22:15

WALTHAM, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory [...]

Biodexa Announces Successful Appeal of Nasdaq Delisting

15/10/2024 - 22:15

Exhibit 99.1 October 15, 2024 Biodexa Announces Successful Appeal of Nasdaq Delisting Biodexa Pharmaceuticals PLC. (the “Company”) (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company [...]

Sanofi: Information concerning the total number of voting rights and shares - September 2024

15/10/2024 - 22:05

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]

Sanofi: Informations relatives au nombre de droits de vote et d'actions - SEPTEMBRE 2024

15/10/2024 - 22:05

Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]

Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024

15/10/2024 - 22:05

SAN DIEGO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its [...]

Interpace Biosciences Announces Capital Restructuring of Its Preferred Stock as a First Step Toward Seeking an Uplisting of Its Common Stock to Nasdaq

15/10/2024 - 22:05

PARSIPPANY, NJ, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that its Series B Preferred Stock investors, Ampersand Capital Partners and 1315 [...]

The Joint Corp. Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

15/10/2024 - 22:05

SCOTTSDALE, Ariz., Oct. 15, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) (“The Joint or “the Company”), the nation’s largest franchisor of chiropractic care through The Joint Chiropractic ® network, today [...]

C4 Therapeutics Appoints Paige Mahaney, Ph.D., as Chief Scientific Officer and Announces Retirement of Stewart Fisher, Ph.D.

15/10/2024 - 22:01

Mahaney Brings More Than 25 Years of Pharmaceutical and Biotech Experience Overseeing Drug Discovery and Expansion of Leading Discovery and Clinical Portfolios Fisher Will Serve as Senior Scientific Advisor Until [...]

Tevogen Bio Takes Lead in Developing Cell Therapies Designed to Eradicate Post Procedure Human Papilloma Virus in Women with Precancerous Cervical Lesions

15/10/2024 - 20:30

Approximately one in three women remain HPV positive after cervical procedures for precancerous lesions. Tens of thousands of women in the US each year are diagnosed with high-grade cervical precancerous lesions. These [...]

Spineway : Continued organic growth - Nine-month 2024 revenue of €9.1 million (+21%)

15/10/2024 - 18:00

Press release Ecully, October 15, 2024 – 6 p.m. SPINEWAY Continued organic growth Nine-month 2024 revenue of €9.1 million (+21%) In thousands of euros 2024 2023 Change % Q1 revenue 3,070 2,398 28% Q2 revenue 3,465 3,033 [...]

SPINEWAY : Poursuite de la croissance organique - Chiffre d’affaires à 9 mois 2024 de 9,1 M€ (+ 21%)

15/10/2024 - 18:00

Communiqué de presse Ecully, le 15 octobre 2024 –18h SPINEWAY Poursuite de la croissance organique Chiffre d’affaires à 9 mois 2024 de 9,1 M€ (+ 21%) En milliers d’euros 2024 2023 Variation en % CA 1 er trimestre 3 070 [...]

Trethera Announces Presentation at the Rare Neuroimmune Disorders Symposium Annual Meeting

15/10/2024 - 17:48

LOS ANGELES, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of [...]

EUROAPI closes the financing of its FOCUS-27 plan

15/10/2024 - 17:45

Press Release Paris - 15 October 2024 - EUROAPI today announces the closing of the refinanced Credit Revolving Facility (RCF) and the Perpetual Deeply Subordinated Hybrid Bond subscribed by Sanofi, thus completing the [...]

EUROAPI clôt le financement de son plan FOCUS-27

15/10/2024 - 17:45

Communiqué de presse Paris - Le 15 octobre 2024 - EUROAPI annonce avoir clos le refinancement du contrat de crédit RCF (Credit Revolving Facility) et l’Obligation Hybride Perpétuelle Super Subordonnée souscrite par [...]

ARC Fertility Selected for BenefitsPRO’s 2024 Luminaries Awards for Humanizing Benefits

15/10/2024 - 16:02

CUPERTINO, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- ARC Fertility (ARC), a highly experienced national provider of innovative fertility, family-forming and women’s and men’s health benefits for employers and their [...]